The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Proliferative Diabetic Retinopathy (PDR) Market Over The 2026–2030 Period?
The market size for proliferative diabetic retinopathy (pdr) has shown rapid growth in recent years. It is projected to increase from $2.69 billion in 2025 to $2.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.3%. This historical expansion can be attributed to various factors, including the rising prevalence of diabetes mellitus, the broader adoption of retinal laser therapies, the proliferation of ophthalmology clinics, enhanced access to eye care services, and the development of diabetic screening programs.
The proliferative diabetic retinopathy (PDR) market size is projected to experience substantial growth in the upcoming years, with an anticipated expansion to $4.49 billion by 2030, reflecting a compound annual growth rate (CAGR) of 11.0%. This projected growth can be attributed to several factors including an escalating demand for long-acting injectable therapies, the increasing embrace of AI-based retinal diagnostics, the broadening availability of outpatient ophthalmic procedures, a heightened focus on strategies for vision preservation, and greater investment in the management of diabetic eye diseases. Key trends expected within this forecast period encompass the rising adoption of anti-VEGF therapies, more frequent use of advanced retinal imaging technologies, an increased emphasis on early screening and diagnosis, the expansion of minimally invasive surgical interventions, and enhanced integration of multidisciplinary diabetes care approaches.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12911&type=smp
Which Major Factors Are Driving The Expansion Of The Proliferative Diabetic Retinopathy (PDR) Market?
The increasing incidence of diabetes is projected to boost the expansion of the proliferative diabetic retinopathy (PDR) market in the future. Diabetes, a chronic medical condition marked by elevated blood glucose (sugar) levels, is the primary cause of proliferative diabetic retinopathy, a disease treatable by various methods to prevent further retinal damage and preserve vision. For instance, the National Health Service (NHS) in the UK reported in June 2024 an increase in individuals under 40 from 173,166 in 2022 to 216,440 in 2023. This significant growth highlights a concerning trend and a rapid escalation in diabetes prevalence among younger populations. Consequently, the growing occurrence of diabetes fuels the proliferative diabetic retinopathy (PDR) market.
How Is The Proliferative Diabetic Retinopathy (PDR) Market Segmented Across Key Categories?
The proliferative diabetic retinopathy (pdr) market covered in this report is segmented –
1) By Treatment Type: Anti-VEGF (Vascular Endothelial Growth Factor) Therapy, Intraocular Steroids, Laser Surgery, Vitrectomy
2) By Mode of Administration: Injectables, Intravitreal Administration Focus, Other Mode Of Administrations
3) By Application: Hospitals, Clinics, Other Applications
Subsegments:
1) By Anti-VEGF Therapy: Aflibercept, Ranibizumab, Bevacizumab
2) By Intraocular Steroids: Triamcinolone Acetonide, Dexamethasone Implant, Fluocinolone Acetonide
3) By Laser Surgery: Focal Laser Photocoagulation, Panretinal Laser Photocoagulation
4) By Vitrectomy: Pars Plana Vitrectomy, Anterior Vitrectomy
What Trends Are Affecting The Expansion Of The Proliferative Diabetic Retinopathy (PDR) Market?
Leading companies active in the proliferative diabetic retinopathy (PDR) market are concentrating on developing innovative solutions, such as AI-based autonomous retinal screening systems and handheld fundus cameras, to enhance early detection and improve patient outcomes. AI-based autonomous screening systems are designed to analyze retinal images without human intervention, providing rapid and accurate identification of diabetic retinopathy, while handheld fundus cameras allow portable and accessible retinal imaging. For instance, in April 2024, Optomed Plc, a Finland-based medical technology company, received U.S. Food and Drug Administration (FDA) clearance for its Optomed Aurora with AEYE, a handheld AI fundus camera capable of autonomously detecting referable diabetic retinopathy, thereby expanding the accessibility and efficiency of PDR screening beyond traditional clinical settings.
Who Are The Dominant Players Shaping The Proliferative Diabetic Retinopathy (PDR) Market Landscape?
Major companies operating in the proliferative diabetic retinopathy (pdr) market are Johnson And Johnson Limited, F Hoffmann La Roche Ltd, AbbVie Inc, Bayer AG, Novartis AG, Merck KGaA, Kubota Vision Inc, Teva Pharmaceutical Industries Ltd, Regeneron Pharmaceuticals Inc, Mylan NV, Santen Pharmaceutical Co Ltd, Lupin Limited, Genentech Inc, Alcon Inc, Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co Ltd, Bausch And Lomb Corporation, Heidelberg Engineering GmbH, Iridex Corporation, Lumenis Ltd, Optos plc, Zeiss Meditec India Pvt Ltd, Alimera Sciences Inc
Read the full proliferative diabetic retinopathy (pdr) market report here:
Which Region Currently Holds The Largest Share Of The Proliferative Diabetic Retinopathy (PDR) Market?
North America was the largest region in the proliferative diabetic retinopathy market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the proliferative diabetic retinopathy (pdr) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Proliferative Diabetic Retinopathy (PDR) Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12911&type=smp
Browse Through More Reports Similar to the Global Proliferative Diabetic Retinopathy (PDR) Market 2026, By The Business Research Company
Encephalitis Treatment Global Market Report
https://www.thebusinessresearchcompany.com/report/encephalitis-treatment-global-market-report
Dysphagia Management Global Market Report
https://www.thebusinessresearchcompany.com/report/dysphagia-management-global-market-report
Rare Neurological Disease Treatment Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model